The store will not work correctly when cookies are disabled.
5-chloro-2-(2-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)ethyl)-1H-inden-1-one
ID: ALA4556093
PubChem CID: 155556668
Max Phase: Preclinical
Molecular Formula: C22H22Cl2N2O
Molecular Weight: 401.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(CCN2CCCN(c3ccc(Cl)cc3)CC2)=Cc2cc(Cl)ccc21
Standard InChI: InChI=1S/C22H22Cl2N2O/c23-18-2-5-20(6-3-18)26-10-1-9-25(12-13-26)11-8-16-14-17-15-19(24)4-7-21(17)22(16)27/h2-7,14-15H,1,8-13H2
Standard InChI Key: ZPZUHCZXEFEFGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
19.0421 -16.2652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4455 -15.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2590 -15.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3416 -17.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8659 -15.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1290 -17.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8057 -16.8018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5193 -17.2074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5193 -18.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2279 -18.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9390 -18.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9329 -17.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2196 -16.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2176 -16.2572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7980 -16.9650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9767 -16.9570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4949 -16.2861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4820 -17.6165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7073 -17.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7166 -16.5343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0134 -16.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3003 -16.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2950 -17.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9988 -17.7555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7563 -15.5063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6531 -18.4285 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.5806 -17.7501 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
1 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 20 1 0
19 18 1 0
18 16 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
17 25 2 0
11 26 1 0
23 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 401.34 | Molecular Weight (Monoisotopic): 400.1109 | AlogP: 5.18 | #Rotatable Bonds: 4 |
Polar Surface Area: 23.55 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.41 | CX LogP: 5.04 | CX LogD: 3.99 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -0.77 |
References
1. Asong G, Zhu XY, Bricker B, Andey T, Amissah F, Lamango N, Ablordeppey SY.. (2019) New analogs of SYA013 as sigma-2 ligands with anticancer activity., 27 (12): [PMID:30987780] [10.1016/j.bmc.2019.04.012] |